NCT01634789View on ClinicalTrials.gov

A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Healthy
Interventions
DRUG

bazedoxifene

20 mg oral tablet, single dose

DRUG

bazedoxifene

20 mg oral tablet, single dose

DRUG

bazedoxifene

20 mg oral tablet, single dose

DRUG

bazedoxifene/conjugated estrogens

20 mg / 0.625 mg oral tablet, single dose

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01634789 - A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women | Biotech Hunter | Biotech Hunter